Bone has a high potential to regenerate, yet it takes over 3 months for an adult human fracture to heal. Nonunions and fractures with massive bone defects or osteopenia require much more time for complete union. In such cases, bone grafting procedures are often hampered by difficulties in obtaining sufficient bone fusion. In the first half of fracture healing process, the fracture callus (a bridging scaffold), consisting of cartilage and woven bone, appears between the fractured stumps. For a complete union, bony tissues must replace the fracture callus. The time of fracture healing depends on this matrix-replacement step. The administration of anabolic factors (bone morphogenetic proteins, basic fibroblast growth factors, etc.) was shown to successfully heal the fractures of experimental models. [1] [2] [3] However, the fracture callus induced by these anabolic factors was bulky, so it took a long time for the callus to be replaced by mature bone tissue.
An alternative procedure to hasten fracture repair is by gene therapy. The adenovirus vector has a high transfection efficiency and is often used as the vehicle for delivering genes in human gene therapy protocols. However, patients still have to receive a high level of virus to obtain a sufficient gene expression. To obtain sufficient transfection efficiency for treating bone fractures by gene therapy with a low dose of adenovirus, we focused on the target cells infected by the virus.
Adenovirus invades its target cells through binding to CAR on the cell membrane. 4 The function of CAR is still unclear. Its expression is highly variable among tissues with highest expression in the liver. Intriguingly, CAR often seems to be induced on regenerating cells. CAR is not usually detectable in normal mature rat hearts. However, CAR is induced on the regenerating cells in an adult rat model of autoimmune-mediated myocarditis. 5 We also observed that some osteosarcoma cells and the osteoblast-like MC3T3-E1 cells (Riken, Tsukuba, Japan) expressed CAR mRNA (data not shown). In addition, adenovirus vector-transduced human bone marrow mesenchymal progenitor cells differentiate into the osteoblastic, but not into the adipocytic lineage. 6 The present study demonstrated that immature osteoblasts in the fracture callus express CAR. The marker gene could be transfected in these CAR-positive cells at a low dose of adenoviruses. Our results support the idea that CARmediated gene transfer should give sufficient gene expression for fracture repair with a lower dose of adenoviral vector.
We first evaluated the time course of histological changes in a mouse bone-fracture model, making observations on 1, 5, 10, 14, and 21 days after rib fracture. Three developmental phases of the fracture healing process, 7 inflammation, repair, and remodeling, were observed in sequence. During the inflammatory phase (day 1), the osteocytes close to the fracture site died and we could not detect the bone or cartilage formation ( Figure 1a ). In the reparative phase (days 5-10), intramembranous bone formation was observed in the periosteal region. Chondrogenesis was also observed in the thickened periosteum. On day 5, hypertrophic chondrocytes appeared besides cortical bone. We identified myoblasts, proliferating in the damaged muscles near the fracture sites, only on day 5 ( Figure 1b) . On day 10, fracture callus grew, and vascular cavities began to invade the callus (Figure 1c ). In the remodeling phase (days 14-21), new trabecular bone formation by endochondral ossification was observed (Figure 1d ). The amount of fracture callus peaked on day 14. On day 21, we observed bone remodeling in the callus, which was followed by bridging the fracture gap and uniting the fracture fragments (Figure 1e ). We next examined the expression of CAR mRNA associated with fracture healing by qualitative RT-PCR. CAR mRNA expression was identified in the fractured ribs at each time point (Figure 2a ). As expected, CAR mRNA could not be identified in the group receiving the sham operation, which only consisted of the skin incision (Figure 2b) . We then performed quantitative RT-PCR using a LightCycler (Roche Diagnostics, Mannheim, Germany), which demonstrated a sequential expression Figure 1 Histological features of rib fracture healing in mice. We used ICR male mice (5-6 weeks old, Charles River Japan Inc, Yokohama, Japan). A transverse fracture was made on the right eighth rib of each mouse using scissors as previously described.
14 Three mice in each group were killed on days 1, 5, 10, 14, and 21. The fractured ribs with surrounding soft tissues of about 5 Â 5 Â 1 mm 3 in size were harvested and fixed with 4% paraformaldehyde in 0.1 mol/l phosphate buffer, decalcified in 0.5 M EDTA (pH 7.5) solution, and embedded in paraffin (HE) wax. Serial 4-mm-thick sections were cut, mounted on 3-aminopropyltriethoxysilane-coated glass slides (Matsunami Glass, Osaka, Japan), and stored at 41C for the following analyses. Hematoxylin and eosin staining was performed on days 1 (a), 5 (b), 10 (c), 14 (d), and 21 (e) after fracture. *, fracture site; mc, myocyte; hm, hematoma (hematoma disappeared during the preparation of sections); cb, cortical bone; po, periosteum; hc, hypertrophic chondrocyte; mb, myoblast; vc, vascular cavity; nb, new trabecular bone formation; Bar, 100 mm. Figure 2 Analysis of CAR and glyceraldehyde-3-phosphate dehydrogenase (G3PDH) mRNA expression in the fracture callus by qualitative RT-PCR. Two mice in each group were killed on days 1, 5, 10, 14, and 21 after the operation. The fractured ribs were harvested together with the surrounding soft tissues of about 5 Â 5 Â 1 mm 3 in size. Total RNA was isolated from the samples using Isogen (Nippon Gene, Tokyo, Japan), and CAR or G3PDH mRNA was detected by RT-PCR. 15 Total RNA (2 mg) were treated with DNase I amplification grade (Invitrogen Corp, Carlsbad, CA, USA) to eliminate contaminated genomic DNA, and converted to cDNA by M-MLV reverse transcriptase (Invitrogen Corp). Diluted cDNAs at 1:100 were used to amplify the mouse CAR and G3PDH genes. We used specific primers as follows: CAR backward primer, 5
The lengths of the expected products were 287 bp for the CAR mRNA and 664 bp for the G3PDH mRNA. The PCR protocol consisted of an initial denaturation for 2 min at 941C, then 40 cycles of denaturation for 30 s at 941C, annealing for 30 s at 561C, and extension for 30 s at 721C, and final extension for 5 min at 721C. The PCR products were analyzed by 1.5% agarose gel electrophoresis. 
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T Ito et al of CAR mRNA that peaked on day 5 and decreased with time thereafter (Figure 3 ). Using an ABI PRISM 310 Genetic Analyzer (Applied Biosystem, Tokyo, Japan), we confirmed that the sequences of the PCR products were in complete agreement with mouse CAR mRNA (Gene bank Accession Number; AK004978).
To clarify the localization of CAR-positive cells, we performed an immunohistochemical analysis of the fracture site. On day 5, the myoblasts were positive for CAR protein (Figure 4c ). We never identified CAR protein in the mature myocytes (Figure 4d ). Fibroblastlike cells in the interface between the hypertrophic chondrocytes and the vascular cavities showed intense signals for CAR protein on days 10 and 14 ( Figure 4g ). We predicted that these fibroblast-like cells were immature osteoblasts based on their morphology and distribution.
To determine the phenotypes of the fibroblast-like cells, the expression and distribution of cell-type-specific mRNAs were analyzed by in situ hybridization and immunohistochemistry. During skeletal development, immature osteoblasts express type I collagen and osteopontin mRNAs, but lack osteocalcin mRNA. 8, 9 CAR-positive fibroblast-like cells in our study also showed this pattern of mRNA expression, detected by double stain of in situ hybridization and immunohistochemistry (Figures 5c-e and 6a-c). Taking these findings together, we concluded that the CAR-positive fibroblasts in the fracture callus were immature osteoblasts.
We next examined whether it was possible to transfer the lacZ gene into the CAR-positive cells in the fracture callus. Adenovirus-mediated transfection studies in bone tissues usually required a high dose of adenovirus vector, over 10 6 plaque-forming units (PFU). 10, 11 In the Figure 3 Quantification of CAR mRNA expression. To quantify the expression of CAR mRNA, the cDNAs were subjected to quantitative PCR using a LightCyclerTM V3 System (Roche Diagnostics). The PCR was conducted in capillary reaction tube cuvettes using 1 ml (10 pmol) of the backward and forward primer, 2 ml of LightCyclerTM FastStart DNA Master SYBR Green (Roche Diagnostics), 2 ml of MgCl 2 (25 mM), 12 ml of distilled water, and 5 ml of diluted cDNA samples at 1:100. The PCR protocol was as follows: dissociation of Taq antibody for 10 min at 951C, then 40 cycles of denaturation for 0 s at 951C, annealing for 10 s at 621C, and extension for 13 s at 721C. To construct melting curves of the PCR products, an additional protocol, implemented following the completion of 40 cycles of PCR, consisted of 10 s at 631C and 0 s at 961C. The transition from 63 to 961C was effected in 0.21C steps with continuous fluorescence monitoring, plotting loss of fluorescence versus temperature. Triplicate cDNAs for each of three separate studies were subjected to this quantitative PCR. The LightCycler data were analyzed using the LightCycler analysis software according to the manufacturer's instructions. The crude data were normalized to the expression of G3PDH mRNA. All these PCR assays were repeated at least three times to confirm the reproducibility of the results. Error bars are not shown for some data points because of low variability. Figure 4 Localization of CAR protein in healing fractures by immunohistochemistry. We used an antibody that reacted with a 17-amino-acid region (KTQYNQVPSEDFERAPQ) in an intracellular domain of the mouse CAR protein. 16 The sections were deparaffinized, rehydrated, and digested with 0.1% trypsin in phosphate-buffered saline (PBS) at 371C for 30 min. Endogenous peroxidase activity was blocked with 0.3% hydrogen peroxide in methanol for 30 min. The sections were rinsed in PBS; blocked with 10% normal goat serum in PBS for 30 min, incubated at 41C for 6 h with purified rabbit anti-mouse CAR antibody at a 1:200 dilution in 5% normal goat serum, and rinsed in PBS followed by incubation with a biotinylated anti-rabbit IgG (Vector, Burlingame, CA, USA) at 1:100 dilution at 371C for 1 h. After the reaction with streptavidin-horseradish peroxidase conjugate, immunoreactivity was visualized with diaminobenzidine. The sections were counterstained with hematoxylin. For the control study, preimmune serum was used at the same concentration. Mouse liver sections were used as positive controls for CAR. These immunohistochemistry assays were repeated at least three times with samples harvested from different animals. CAR-positive cells were myoblasts on day 5 (a and b: HE staining, c: immunohistochemistry) and fibroblast-like cells on days 10 (e and f: HE staining, g: immunohistochemistry) and 14. On day 10, the fibroblast-like cells were located in the interface between hypertrophic chondrocyte and vascular cavity. The square in (a) and (e) indicates the area shown in (b) and (f). CAR protein was not detected in the normal rib (d). *, fracture site; white arrowhead, myoblast; black arrowhead, hypertrophic chondrocyte; white arrow, vascular cavity; black arrow, fibroblast-like cell; mc, myocyte; po, periosteum; cb, cortical bone; bm, bone marrow; Figure ( (Figure 8b ). Double-antibody immunofluorescene staining showed areas of yellow fluorescence, suggesting that these cells produced bgalactosidase as well as CAR (Figure 8c) . Thus, the susceptibility of the CAR-positive immature osteoblasts Figure 5 Analysis of the expression and distribution of cell-type-specific mRNAs by in situ hybridization. In situ hybridization was carried out as previously described. 17 Plasmids containing the 1.0-and 0.47-kb fragments of mouse osteopontin and osteocalcin cDNAs were kindly provided by Dr S Nomura (Department of Pathology, Osaka University Graduate School, Osaka, Japan). A plasmid containing 0.37 kb of mouse a1 type I procollagen cDNA was a gift from the Life Science Research Institute (Asahi Chemical Industry, Shizuoka, Japan). The sections were digested in 5 mg/ml of proteinase K solution (Roche Diagnostics) at 371C for 10 min, then hybridized with approximately 0.5 mg/ml of probes in hybridization buffer at 501C for 16 h. After washing and treatment with 10 mg/ml of RNase-A (Roche Diagnostics) at 371C for 30 min, the signals were detected using the DIG detection kit (Roche Diagnostics). The positive signals were blue. In situ hybridization assays for each mRNA were repeated at least three times using samples harvested from different animals. Serial sections on day 10 were used. Immunohistochemistry of CAR protein (b), in situ hybridization of type I collagen, osteopontin, and osteocalcin mRNAs (c-e). (f) is a schema that explains the location of vascular cavies, fibroblast-like cells, and hypertrophic chondrocytes. The square in (a) indicates the area shown in (b-e). Fibroblast-like cells, lining the vascular cavities, exhibited CAR protein, type I collagen, and osteopontin mRNAs, but not osteocalcin mRNA (b-e). Osteocalcin mRNA was detected in the cuboidal osteoblasts lining the newly formed trabeculae in the remodeling callus (e). *, fracture site; black arrowhead, hypertrophic chondrocytes; white arrowhead, cuboidal osteoblasts; black arrow, fibroblast-like cells; white arrow, vascular cavity; fc, fibroblast-like cells; vc, vascular cavity; hc, hypertrophic chondrocyte. (a) and (b) are same as Figure 4e and g. Bar, 100 mm. Figure 6 Phenotype determination of the CAR-positive fibroblast-like cells by double stain of in situ hybridization and immunohistochemistry. The sections were rinsed three times in PBS and the in situ hybridization was followed by the immunohistochemical procedure from the step of digestation with 0.1% trypsin as described before. The CAR-positive cells were detected as brown, and the type I collagen or osteopontin mRNAs were detected as purple. Double-stained cells were detected as gray. Some of the CAR-positive cells expressed type I collagen and osteopontin mRNAs (a and b), but not osteocalcin mRNA (c). Black arrow, CARpositive fibroblast-like cells; white arrow, CAR and type I collagen or osteopontin-positive fibroblast-like cells. Bar, 50 mm.
T Ito et al to the adenovirus vector resulted in successful gene transfer at a low dose of adenovirus without affecting other cells. We speculate that other tissues containing CAR-expressing cells in the regenerating state could also be targeted by CAR-mediated adenovirus transfection. We also detected CAR protein in myoblasts near the fracture site. This was consistent with the report of Baltzer in which high levels of transgene expression were identified in the muscle surrounding the bone defect Figure 7 Gene transfer into CAR-positive cells in the fracture callus by low levels of adenovirus. We examined whether adenovirus vectors Ad 5-CAG (cytomegalovirus enhancer, chicken b-actin promoter, rabbit b-globin poly A signal)-lacZ harboring lacZ gene of Escherichia coli (Takara, Shiga, Japan) invaded the CAR-positive cells in the fracture callus. A collagen sponge, Integran (Nippon Zoki, Osaka, Japan), containing 10 ml of virus suspension in PBS was placed on the fracture callus for 2 days. This sponge was made from bovine collagen and the size was 3 Â 3 Â 1 mm 3 . The recombinant adenovirus was produced by cotransfecting 293 cells with cosmid pAxCAiLacZ and the DNA-TPC by the calcium-phosphate method. The viruses were purified through CsCl gradients followed by dialysis, and stored at À801C in PBS. Virus titer was determined by plaque-forming assays. The fracture callus was infected with adenovirus at 10 8 , 10
6
, and 10 4 PFU. As the callus on day 10 was too small to handle, the callus on day 14 was used for this study. After 2 days, four mice in each group were killed and the fractured ribs with surrounding soft tissues of about 5 Â 5 Â 1 mm 3 in size were harvested together. b-Galactosidase activity was identified using X-gal (5-bromo-4-chloro-3-indolyl-b-Dgalactopyranosine) as a substrate. The samples and negative controls were incubated with 0.2 mM MgCl 2 , 5% Nonidet P-40 (Nacalai techque, Kyoto, Japan), 1 mg/ml X-gal, 5 mM potassium ferricyanide, and PBS (pH 7.4) at 371C for 3 h. After staining, the samples were thoroughly rinsed with PBS and fixed overnight with 4% paraformaldehyde in 0.1 mol/l phosphate buffer. The samples were decalcified in 0.5 mol/l EDTA solution, and embedded in paraffin wax. The tissue was cut into 4-mm-thick sections, which were deparaffinized, rehydrated, and counterstained with Kernechtrot stain solution (Muto Pure Chemicals, Tokyo, Japan) for 2 min at room temperature. The X-gal staining assays were repeated at least four times to confirm the reproducibility. b-Galactosidase activity was identified in immature osteoblasts at the interface between the hypertrophic chondrocytes and the vascular cavities at each dose. Ltd., Tokyo, Japan). Using a cryostat (Leica CM3050S, Leica Instruments, Wetzlar, Germany) 4-mm-thick sections were cut, mounted on 3-aminopropyltriethoxysilane-coated glass slides, and stored at À201C for the following analyses. The sections were rehydrated in PBS, and digested with 0.1% trypsin in PBS at 371C for 20 min. The sections were rinsed in PBS, blocked with 10% normal goat serum in PBS for 30 min, incubated at 41C for 6 h with anti-mouse CAR polyclonal antibody (1:200 dilution), and anti-b-galactosidase monoclonal antibody (1:50 dilution). The sections were rinsed in PBS followed by incubation with FITC-conjugated and TRITC-conjugated secondary antibody for 30 min at room temperature. By using of an IX70 laser-scanning microscope (Olympus Promarketing, Tokyo, Japan), we took the pictures using the appropriate filter setting for FITC and TRITC. Adobe Photoshop (Adobe Systems, San Jose, CA, USA) was used for image handling. The CAR-positive cells were detected as green fluorescence (a), and the b-galactosidase were detected as red (b). Double-stained cells were detected as yellow (c). For the control study, preimmune serum was used at the same concentration. White arrow, CAR and b-galactosidase-positive immature osteoblasts. Bar, 50 mm.
CAR in fracture healing T Ito et al after injection of adenovirus vectors. 12 This finding also could explain why the CAR mRNA level peaked on day 5, before the appearance of immature osteoblasts.
The replacement of cartilage matrix by bone tissue is essential to complete the bridging between fracture stumps. Even though the myoblasts contained CAR in the early phase of fracture healing, they would not be effective targets for adenovirus-mediated gene therapy because the myoblasts never colocalize with the callus. We previously reported that the immature osteoblasts located at the interface between cartilage and bone express the mRNA for matrix metalloproteinase, which degrades the cartilage matrix in the callus. 13 Therefore, these immature osteoblasts are suitable targets for gene therapy designed to hasten matrix replacement. Here, as a step towards that goal, we demonstrated successful CAR-mediated gene transfer at a low dose of adenovirus to the site of fracture healing.
